Page last updated: 2024-10-19

thioctic acid and Cerebral Pseudosclerosis

thioctic acid has been researched along with Cerebral Pseudosclerosis in 7 studies

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

Research Excerpts

ExcerptRelevanceReference
"Wilson disease is an autosomal recessive genetic disorder caused by loss-of-function mutations in the P-type copper ATPase, ATP7B, which leads to toxic accumulation of copper mainly in the liver and brain."1.48Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent. ( Bragina, O; Järving, I; Kabin, E; Palumaa, P; Plitz, T; Smirnova, J; Tõugu, V, 2018)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smirnova, J1
Kabin, E1
Järving, I1
Bragina, O1
Tõugu, V1
Plitz, T1
Palumaa, P1
da COSTA, S3
RODRIGUES, EM2
da SILVA, J3
RELVAS, ME2
HALPERN, MJ2
DA COSTA, SF1
DA SILVA, JA1
Dabski, H1
Gomes da Costa, SF1

Reviews

1 review available for thioctic acid and Cerebral Pseudosclerosis

ArticleYear
[Clinical use of thioctic acid].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1969, Sep-30, Volume: 24, Issue:39

    Topics: Animals; Brain Chemistry; Diabetes Mellitus; Diuretics; Glycogen; Hepatolenticular Degeneration; Hum

1969

Other Studies

6 other studies available for thioctic acid and Cerebral Pseudosclerosis

ArticleYear
Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent.
    Scientific reports, 2018, 01-23, Volume: 8, Issue:1

    Topics: Apoptosis; Carrier Proteins; Cell Line; Cell Proliferation; Chelating Agents; Copper; Copper Transpo

2018
[On the biochemical pathology of Wilson's disease. New observations on the action of alpha-liponic acid].
    Arzneimittel-Forschung, 1961, Volume: 11

    Topics: Hepatolenticular Degeneration; Humans; Thioctic Acid

1961
[On the pathogenesis and therapy of Wilson's disease. The effect of alpha-lipoic acid (preliminary communication)].
    Arzneimittel-Forschung, 1960, Volume: 10

    Topics: Hepatolenticular Degeneration; Humans; Thioctic Acid

1960
[On the therapy of Wilson's disease].
    Arzneimittel-Forschung, 1963, Volume: 13

    Topics: Hepatolenticular Degeneration; Humans; Thioctic Acid; Vitamin A

1963
[METABOLIC SIGNIFICANCE OF ALPHA-LIPOIC ACID. 3. ALPHA-LIPOIC ACID AND IRON METABOLISM. (PRELIMINARY NOTE)].
    Jornal da Sociedade das Ciencias Medicas de Lisboa, 1963, Volume: 127

    Topics: Anemia; Corrinoids; Hematinics; Hemochromatosis; Hepatolenticular Degeneration; Humans; Iron; Pharma

1963
[Morbus Wilson and possible therapeutic significance of lipoic acid].
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:9

    Topics: Copper; Depression, Chemical; Diuresis; Hepatolenticular Degeneration; Humans; Liver Function Tests;

1970